GX 623
Generic Name: abacavir
Pill imprint GX 623 has been identified as Ziagen 300 mg.
Ziagen is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy.
Ziagen 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Ziagen Images
- Generic Name:
- abacavir
- Imprint:
-
GX 623
- Strength:
- 300 mg
- Color:
- Yellow
- Size:
- 18.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
hypromellose
polysorbate 80
ferric oxide yellow
triacetin
titanium dioxide
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0661
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-4883 | A S Medication Solutions LLC (repackager) |
| 54868-4522 | Physicians Total Care Inc (repackager) |
| 35356-0075 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Ziagen resources
Search Again
